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Abstract
Currently, in the management of acute diarrhea, underuse of oral rehydration solutions (ORS), is still reported, being a strong rationale for their improvement to increase patient’s 
acceptability and, in consequence, treatment compliance and therapeutic success, for example, in terms of palatability, and swallowability.
In this article, we reviewed the advantages of new ORS gel formulations, with solid or semi-solid texture, that could help to overcome the inconveniences of conventional ORS. The 
main difficulty, the salty taste, can be masked using flavors, reconstituting and administering the gel product at low temperatures or using pleasant textures that resembles desserts 
or sweets. 
Another important critical point in the oral rehydration is the relatively large volumes administered, usually rejected by children. In gel formulations the volume is significantly 
reduced to around 100ml, and can be administered at small portions, thus avoiding its refusal and facilitating the role of parents or caregivers in administering it. Recent studies 
have shown these benefits, together with the demonstration of the electrolytes release at gastric level. However, more clinical trials are needed to compare gel formulations versus 
standard ORS.
ABBREVIATIONS
AMP: Adenosine Monophosphate; EMA: European 
Medicines Agency; ESPGHAN: European Society for Paediatric 
Gastroenterology Hepatology and Nutrition; ESPID: European 
Society for Paediatric Infectious Diseases; HAMS: High-Amylose 
Maize Starch; NICE: National Institute for Health and Care 
Excellence; ORS: Oral Rehydration Solution; SCFA: Short-chain 
Fatty Acids; WHO: World Health Organization
INTRODUCTION 
Nowadays, acute gastroenteritis continues to be one of the 
most common infectious diseases, with an estimated 5 billion 
episodes occurring worldwide each year [1], and is still one of the 
main causes of morbidity and mortality, particularly in children 
in low-income countries  [2-5]. In Europe, it is estimated that the 
incidence of diarrhea ranges from 0.5 to 1.9 episodes per child 
per year in children up to 3 years of age [4,5]. In developing 
countries, acute diarrhea represents the third cause of death 
(15%), in children under the age of 5, after perinatal death (23%), 
and acute respiratory infection (18%) [3]. 
Acute gastroenteritis is often characterised by diarrhea 
of rapid onset, with or without nausea, vomiting, fever, or 
abdominal pain[6]. Profuse watery diarrhea may frequently 
lead to substantial fluid losses, dehydration, that can be severe 
if adequate rehydration is not provided [7], thus becoming a 
self-limiting condition, particularly in children [7]. In fact, acute 
gastroenteritis often has an impact on different levels such as 
public health, health burden (primary care and hospital), psyco-
social impact for the family, laboral costs, etc[8-11]. 
Despite the wide range of available products for the 
management of acute diarrhea [5], such as antibiotics, motility 
inhibitors, substances that decrease water and electrolyte 
secretion such as racecadotril, hydrated aluminomagnesium 
silicates, such as diosmectite [12], or mucosal protectors such as 
xyloglucan [5,13-16], treatment with hypotonic oral rehydration 
solutions (ORS), remains the mainstay of the management of 
acute gastroenteritis in most cases [5,13,17-19]. 
Despite their widespread use for decades, underuse of ORS 
is still reported[5,7], due to a variety of reasons. In this review, 
we analyzed the possible causes of ORS underuse and current 
evidences highlighting the advantages of new solid or semi-solid 
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ORS formulations to increase patient acceptability, particularly 
in children. 
REASONS FOR ORS UNDERUSE 
According to the ESPGHAN/ESPID and NICE guidelines, 
fast oral rehydration with rapid return to regular food is 
recommended [5,20].
ORS is a solution containing glucose and salt that allows 
electrogenic solute intestinal absorption, essential to replace 
fluid losses during acute gastroenteritis, being considered as the 
most important medical advance of the 20th century [19,21] and 
the cheapest and simplest intervention that saved more lives 
than any other drug [19]. 
Another milestone in the development of ORS was the 
demonstration that the hypo-osmolar formulations (≤ 270 
mOsm/kg H2O) were more efficacious than the initial iso-
osmolar (311 mOsm/kg H2O) ORS formulations (often referred 
to as WHO-ORS) in correcting acute dehydration and metabolic 
acidosis, commonly containing glucose, NaCl, KCl and sodium 
citrate [7,21,22]. 
Despite their proven efficacy, ORS remains underused, 
particularly in developed countries [22,24], mainly due two 
main reasons: the perception of inefficacy by children, parents 
or caregivers and their unappealing organoleptic properties. In 
the first case, ORS do not always alter the course of the disease 
(in terms of fluid loss, bowel movements or duration of diarrhea) 
thus leading to discontinuation of the treatment [5]. In this case, 
the perceptions of parents and caregivers about the importance 
of rapid rehydration can also influence the degree of ORS 
compliance and, in consequence, therapeutic success[7,25]. For 
example, it has been reported that the parents can feel much more 
interest in stopping main children symptoms, such as diarrhea, 
than in rehydrating and correcting the metabolic acidosis [7]. 
It is also in the paediatric population where ORS organoleptic 
properties, mainly their salty taste, are mainly responsible for 
their low acceptability, leading to low compliance rates[23,26-28]. 
Other causes for low adherence include the high volumes of fluid 
intake [29,30], usually provided at a large number of intervals 
[24,31], and the liquid state, which could be contraindicated in 
children with vomiting[24,32,33]. In the hospital emergency 
departments, the intake of large volumes of ORS can also 
represent a problem, with time constraints, space limitations and 
slow intakes[31,32]. 
In fact, many efforts have been made to improve ORS 
organoleptic properties, with the addition of different 
components. Any of them, however, has not provided special 
success without the implementation in the clinical practice. 
In this article, we review the main inconveniences of 
available ORS and new reported strategies to increase treatment 
compliance, with the use of solid or semi-solid ORS formulations. 
ORS ACCEPTABILITY AND IMPROVEMENT 
STRATEGIES
According to the European Medicines Agency (EMA), 
acceptability is “the overall ability and willingness of the patient 
to use a medicinal product as intended and its caregiver to 
administer the medicine as intended”, emphasizing the need 
to evaluate patient acceptability as an integral part of the 
pharmaceutical development [34]. Medicinal products that are 
unpleasant or cause stress are more likely to be rejected by 
children or caregivers[27,35].
Patient acceptability is likely to have a significant impact on 
patient adherence and, consequently, on the efficacy of a product. 
Acceptability is determined by the characteristics of the product 
and the user [34]. Factors influencing product acceptability 
include: palatability, swallowability (e.g. size, shape, texture), 
appearance (e.g. colour, shape), complexity of the preparation to 
be conducted by the child or its caregivers prior to administration, 
the required dose (e.g. the dosing volume, number of tablets, 
etc.), the required dosing frequency and duration of treatment, 
the selected administration device, the primary and secondary 
container closure system and the actual mode of administration 
to the child and any related stress, pain or discomfort [34,36]. 
In the case of ORS, many children refuse to drink it because of 
their unappealing organoleptic properties, one important factor 
leading to rehydration treatment failure[23,37]. Therefore, 
one important current challenge in the development of ORS is 
focusing on improving patient acceptability, including not only 
taste, but also texture, appearance or smell [23,27,29,38,39]. 
Other factors influencing acceptability include, for example, the 
large volumes or the role of parents and caregivers. 
In these sections, we review the different aspects of ORS 
influencing acceptability and different strategies to increase it. 
ORS palatability
Sodium is an essential element in the intestinal absorption of 
water, which occurs optimally when the glucose to sodium ratio 
is 1 to 1 [7,37], mediated by the glucose-sodium co-transport in 
the brush border of the mammalian small intestine [7,28,40]. 
Consequently, ORS all have a salty taste, with a higher sodium 
concentration than the most common consumed beverages, 
making them less palatable, particularly in children. In their 
reaction to the ORS salty taste, many children refuse to drink 
and/or regurgitate the mixture[41,25,28], being the main barrier 
for ORS adherence [23,26-28].
Currently, some proposed alternative strategies to reduce 
the strong salty taste are controversial mainly due to the risk 
of modifying the glucose/sodium chloride ratio[19], that could 
avoid full rehydration and worsen diarrhea through osmotic 
mechanisms [19], for example with the addition of rice syrup 
[28], fruit juices [38], carbonated beverages [13], or with home 
flavoring  [28,42]. 
To date, few studies have evaluated palatability of ORS in 
children and the parents’ opinion, an important factor that, 
together with the low insistence of parents to ensure that their 
children complete treatment, reduce ORS effectivity [25,28]. 
In a study in children and adults, te Loo et al., demonstrated 
that only very small amounts of apple juice or orange juice could 
be added to the ORS without significantly altering electrolyte 
composition and osmolality. Moreover, palatability of these new 
solutions did not improve, in comparison with commercially 
flavoured ORS. For this reason, commercially flavoured ORS, 
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which fulfill ESPGHAN criteria, were the recommended options 
[38].
To mask the salty taste, EMA recommends flavours such as 
caramel, grapefruit, lemon, orange and vanilla[35], which could 
be considered in the development of commercially flavoured 
ORS[41]. Variations in children preferences, according to social 
and cultural influences and geographical location, should also be 
considered[25,35].
In a satisfaction study in 156 children and their parents, 
assessing gel and gelatin ORS textures, a 54% of parents had 
experienced problems to administer ORS to their children because 
of its unappealing taste. The most accepted flavours were cola 
and strawberry, while orange was the flavour that most children 
would like to taste if available [27]. In a randomized, single-
blind clinical trial, cola and strawberry were also the preferred 
flavours. Of note, there was an association between children who 
liked cola drinks and preferred the ORS cola flavoured, while no 
relationship was found in the case of strawberry. These results 
highlight the importance of considering children preferences in 
the formulation of ORS [25]. 
In this regard, the effect of temperature could also be 
explored, since low temperatures could reduce the perception of 
salty taste. This effect has been already assessed using frozen ice 
pops, being their acceptance attributed to the ice pop’s appeal, 
better taste or soothing effect[31]. Since it is known that taste 
perception is enhanced as the temperature of food and beverage 
products increases[43], the use of ORS at low temperatures, in 
solid or liquid forms or when reconstituted, in gel formulations, 
should be considered. 
ORS texture
Texture is, after taste, the second main barrier to administer 
oral formulations to children with different diseases[44]. 
However, studies evaluating the influence of texture in the 
acceptability of oral formulations in children are limited[29].
In the satisfaction study performed by Polanco et al., the 
preferred texture by children and parents was the gel texture, 
with a 90% of the parents stating that they would like to try it. 
Both textures, gelatin and gel, together with the added flavors, 
promoted the association with desserts and sweets, avoiding the 
perception of ORS as a medicine [27]. 
Of note, it has also been speculated that the gel texture 
may mask the unpleasant salty taste of electrolytes[23], thus 
supporting the use of new textures, solid or semi-solid, in the 
formulation of ORS in order to improve their acceptability.
ORS smell and appearance
As already described, the appearance of a product can 
influence acceptability, particularly in children, with similarities 
with deserts or sweets [27], and also with ice pops [31], nearer to 
the child’s preferences. It has also been shown that the addition 
of colours to ORS product formulations can improve sensorial 
acceptability [41].
The same considerations should apply to smell, although no 
studies have been assessed this issue. In this regard, it should 
be taken into account that the affective responses to pleasant/
unpleasant odours do not appear in children until the age of 
about 5 and that, after the age of 6, the adult pattern may be 
observed[35,45]. 
Large volumes of ORS
The health condition of children with gastroenteritis is another 
factor that can determine the willingness to accept medications 
and, in particular, ORS, being less co-operative than usual[35]. 
Although liquid products may be preferred and provide high 
dosing flexibility, in the case of ORS, the sick children can spit or 
spill the liquid, have difficulties to swallow large volumes, and 
could vomit it, being the recommended ORS volumes exceeding 
the acceptable volumes for most children [29,30]. 
The large volumes of ORS also affect parents and caregivers, 
who have to learn the correct mode of administration. For 
example, children younger than two years should be given one 
teaspoon every one to two minutes, while older children should 
be encouraged to take frequent sips directly from the cup. If 
vomiting occurs, the recommendation is to wait five to ten 
minutes and then re-start offering the ORS again more slowly, 
every two to three minutes[6,46].
These large volumes also represent a problem in the 
emergency departments, with time constraints, space limitations 
and the difficulties associated with providing 5 mL of fluid 
by mouth every 1-5 minutes [31], in which the most relevant 
outcome measures for emergency physicians include: therapy 
efficacy, time required for efficacy and adverse events[33].
In this regard, we consider that new solid or semi-solid 
ORS formulations could contribute to overcome these barriers, 
with reduced volumes (maximum 150ml), easily administered 
at small portions, and improved flavors and textures, with 
important advantages over the liquid formulations, increasing 
the acceptability in the paediatric population. 
Role of parents and caregivers in the ORS acceptability
Parents and caregivers have an important influence on 
the adherence to ORS treatment, often contributing to its 
underuse[13,25]. The main reason is the refusal of children 
to take ORS, which leads to use or to add fruit juices or other 
beverages that do not fulfill current recommendations [13,25,38], 
avoiding full rehydration and worsening diarrhea through 
osmotic mechanisms [19]. 
Another reason is that parents would be more focused to stop 
the most visible symptoms and signs of gastroenteritis, such as 
diarrhea, vomiting, etc., leaving aside the need of rehydration [7]. 
In any case, continuing education in rehydration therapy 
is still a need for parents and caregivers [7], including the 
recommendations to use ORS. In this regard, solid or semi-soli 
formulations could help parents and caregivers to administer 
the rehydration product, with low amounts (100-150ml), being 
easier to give at intervals and at small portions and regarded as a 
desert by the children, which can also be stored in the refrigerator 
for a while. The use of products that must be reconstituted using 
cold water would also facilitate the product preparation and 
decreasing the salty taste. 
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NEW GELLIFIED PRODUCTS FOR THE 
MANAGEMENT OF ACUTE DIARRHEA
There have been several major efforts to modify the 
composition of ORS with the goal to improve its efficacy to reduce 
diarrhea [7]. In this attempt, it is important that the new products 
fulfill the recommended criteria regarding the glucose/sodium 
ratio and the osmolality range (200-250 mOsm/l), according to 
WHO or ESPGHAN[22]. 
As already stated, one feasible strategy for oral rehydration 
is the development of rehydration products with gel consistency, 
containing glucose and the mineral complexes, different flavours 
and different types of solidifying agents that are degraded at 
colon level and, therefore, they do not interfere in the glucose/
sodium ratio at the absorption site in the small intestine [21]. 
Among the different solidifying agents, well-known matrices 
can be used to provide different solid or semi-solid textures, 
such as xanthan gum[47], and modified resistant starches (such 
as maize) [21]. Other gelling agents such as gelatin, pectin [41], 
agar[48], or gellan gum[49], alone or in combination, could also 
be assessed. 
As already mentioned, these formulations provide many 
advantages versus the liquid formulations, increasing children 
acceptability, such as substantial reduction of volume (around 
100ml), masking of the unpleasant salty taste, similarities with 
deserts or sweets, which can be stored in the refrigerator, 
improved swallowability, more attractive flavour and appearance 
and easier of administration by parents and caregiver. Moreover, 
compared to similar ready-to-use products, formulations in form 
of powders are more convenient in terms of storage, handle, 
transport and shelf-life[24], being provided with devices to 
guarantee precise dosing (Figure 1). One limitation of solid 
products is the minimum age at which the child can eat solid food. 
Despite the numerous advantages described, to date, 
there are few studies comparing solid formulations versus 
conventional ORS. In our opinion, this deserves further research, 
with comparisons in the degree of adherence to treatment, 
children satisfaction and parents’ opinions. 
STUDIES COMPARING SOLID VS LIQUID FORMS
First comparative studies have focused on demonstrating the 
superiority of new ORS that contained resistant starch, specifically 
high-amylose maize starch (HAMS) versus ORS, based on the 
demonstration that the final metabolites of starch in the colon, 
short-chain fatty acids (SCFA), stimulate colonic sodium and fluid 
absorption by a cyclic AMP-independent mechanism [7,21,50], 
although no solid or semi-solid formulations were obtained. 
Figures
Figure 1: Advantages of ORS with gel consistency
 
Figure 1 Advantages of ORS with gel consistency.
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In a randomized-controlled trial performed in children 
aged between 5 and 36 months, Passariello et al., compared 
the standard ORS with banana flavour with a gel hypotonic 
formulation containing zinc, with a vanilla flavour, observing a 
better compliance with the gel formulation and a higher amount 
consumed at 4 and 24 h. The number of children who refused 
taking the product was lower in the gel group. Statistically 
significant differences were reported in the main symptom, 
diarrhea. A significantly shorter duration of diarrhea (p < 0.001), 
and a significantly lower number of patients with diarrhea after 
72 h of treatment (p = 0.028), in the gel group were reported. 
According to the authors, the gel formulation contributed to 
mask the unpleasant salty taste, thus increasing the acceptability 
of children for this formulation[23]. These results support the 
development of products for oral rehydration in gel forms and 
the performance of new comparative clinical trials. 
Another interesting study has been published recently by 
Taylor et al. in which the release of salts from pectin-gelatin 
matrices was assessed under simulated gastric conditions. The 
different ORS gels developed, containing pectin and gelatin, 
showed favorable textural profiles, being able to rapidly release 
salt in gastric conditions [41]. These results suggest that different 
gel formulations of ORS are able to effectively release the salts 
before reaching the absorption site at the small intestine. 
CONCLUSIONS
Currently, in the management of acute diarrhea, particularly 
in children, there is still a need to improve the acceptability 
and adherence to ORS, for example palatability, swallowability, 
appearance or parent’s attitude towards the treatment 
administration. 
In our opinion, the development of new ORS gel formulations 
could help to overcome these disadvantages. The main difficulty, 
the salty taste, can be masked using flavours, reconstituting 
and administering the gel product at low temperatures or using 
pleasant textures that can resemble desserts or sweets. 
Another important critical point in the oral rehydration is 
the volume administered, which children usually do not accept. 
In gel formulations the volume is significantly reduced to around 
100ml, and can be administered at small portions, thus avoiding 
its refusal and facilitating the role of parents or caregivers in 
administering it. Recent comparative studies are demonstrating 
these benefits, together with the demonstration of the electrolytes 
release at gastric level. However, more clinical trials are needed 
to compare gel formulations vs standard ORS. 
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